Non-insulin-dependent diabetes mellitus and Alzheimer's disease

Journal of the American Geriatrics Society

Volumn 45, Issue 5, 1997, Pages 654-

  Landi, Francesco ^a   Bernabei, Roberto ^a   Gambassi, Giovanni ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; AMYLOID; APOLIPOPROTEIN E; GLUCOSE; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE; TACRINE; POTASSIUM CHANNEL;

ALZHEIMER DISEASE; AMYLOIDOSIS; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; COGNITION; DIABETIC PATIENT; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; LETTER; MULTIINFARCT DEMENTIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; POTASSIUM CURRENT; SENILE DEMENTIA; THERAPY EFFECT; WEIGHT REDUCTION; ORAL DRUG ADMINISTRATION;

ALZHEIMER DISEASE; APOLIPOPROTEINS E; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; POTASSIUM CHANNELS;

EID: 0030908190     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1997.tb03108.x     Document Type: Letter

References (8)

1. Nielson KA, Nolan JH, Berchtold NC, et al., Apolipoprotein-E genotyping of diabetic dementia patients: is diabetes rare in Alzheimer's disease. J Am Geriatr Soc 1996; 44: 897-904.
2. Lorenzo A, Yankner BA., Amyloid fibril toxicity in Alzheimer's disease. Ann N Y Acad Sci 1996; 777: 89-95.
3. Halter JB., Alzheimer's disease and non-insulin-dependent diabetes mellitus: Common features do not make common bedfellows. J Am Geriatr Soc 1996; 44: 992-993.
4. Reiman EM, Caselli RJ, Lung SK, et al., Preclinical evidence of Alzheimer's disease in persons homozygous for the 4 allele for apolipoprotein E. N Engl J Med 1996; 334: 752-728.
5. Eliason L, Restrom E, Ammala C, et al., PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic beta cells. Science 1996; 271: 813-815.
6. Crepel V, Krnjevic K, Ben-Ari Y., Sulphonylureas reduce slowly inactivating D-type outward current in rat hippocampal neurons. J Physiol Lond 1993; 466: 39-54.
7. Wagstaff AJ, McTavish D., Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer disease. Drugs Aging 1994; 4: 510-540.
8. Kim CS, Han YF, Etcheberrigaray R, et al., Alzheimer and beta-amyloid-treated fibroblasts demonstrate a decrease in a memory-associated GTP-binding protein, Cp20. Proc Natl Acad Sci USA 1995; 92: 3060-3064.